Following the publication of the PMPRB Draft Guidelines on Nov 21, 2019, PDCI undertook an analysis to critically assess the ... Read More
News
13
Feb2020
14
Jan2020
W. Neil Palmer
In its December 2019 NEWSletter[1], the Patented Medicine Prices Review Board (PMPRB) is “reminding” patentees that ... Read More
13
Jan2020
CADTH’s Pharmaceutical Reviews Updates are used to communicate new CDR and pCODR drug review process updates to the public. ... Read More
06
Jan2020
Recently, the deadline for providing written submissions on the PMPRB’s proposed new Guidelines was extended until January 31, 2020. As part ... Read More
10
Dec2019
Each month the pCPA issues an update on the previous month’s negotiation activity. Below, you will find an overview of ... Read More
27
Nov2019
CADTH’s Pharmaceutical Reviews Updates are used to communicate new CDR and pCODR drug review processes updates to the ... Read More
26
Nov2019
REGISTRATION IS OPEN!
Learn how the new PMPRB amendments and guidelines will ... Read More
22
Nov2019
Each month the pCPA issues an update on the previous month’s negotiation activity. Below, you will find an overview of ... Read More